Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of AFQ056 and nicotine compared to placebo on craving and withdrawal symptoms during voluntary smoking stoppage in healthy smokers. This study will also assess how the body interacts with AFQ056.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00414752
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 1
Start date September 2006

See also
  Status Clinical Trial Phase
Completed NCT05385055 - Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
Completed NCT01210586 - Tobacco Cessation in Postmenopausal Women N/A
Enrolling by invitation NCT05382221 - Breathe 2 Project 3: Comprehensive Chronic Care N/A
Recruiting NCT03556774 - Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program N/A